1. |
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727-733. DOI: 10.1056/NEJMoa2001017.
|
2. |
Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infect, 2020, 9(1): 221-236. DOI: 10.1080/22221751.2020.1719902.
|
3. |
Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565-574. DOI: 10.1080/22221751.2020.1737364.
|
4. |
Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19[J]. Am J Hematol, 2020, 95(12): 1578-1589. DOI: 10.1002/ajh.25982.
|
5. |
Walinjkar JA, Makhija SC, Sharma HR, et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology[J]. Indian J Ophthalmol, 2020, 68(11): 2572-2574. DOI: 10.4103/ijo.IJO_2575_20.
|
6. |
Sheth JU, Narayanan R, Goyal J, et al. Retinal vein occlusion in COVID-19: a novel entity[J]. Indian J Ophthalmol, 2020, 68(10): 2291-2293. DOI: 10.4103/ijo.IJO_2380_20.
|
7. |
Jalink MB, Bronkhorst IHG. A sudden rise of patients with acute macular neuroretinopathy during the COVID-19 pandemic[J]. Case Rep Ophthalmol, 2022, 13(1): 96-103. DOI: 10.1159/000522080.
|
8. |
Valenzuela DA, Groth S, Taubenslag KJ, et al. Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination[J/OL]. Am J Ophthalmol Case Rep, 2021, 24: 101200[2021-09-01]. https://pubmed.ncbi.nlm.nih.gov/34485760/. DOI: 10.1016/j.ajoc.2021.101200.
|
9. |
Sen M, Honavar SG, Sharma N, et al. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19[J]. Indian J Ophthalmol, 2021, 69(3): 488-509. DOI: 10.4103/ijo.IJO_297_21.
|
10. |
Zhang Y, Liu Y, Gao Y, et al. An alarming rise in COVID-19-related acute macular neuroretinopathy in China: a cross-sectional multimodal imaging study[J]. J Travel Med, 2023, 30(5): 109. DOI: 10.1093/jtm/taad109.
|
11. |
Xu B, Zhang J, Zhang Y, et al. Transient increase in patient numbers with "acute macular neuroretinopathy" post SARS-CoV-2 infection-case series during the first surge of infection in december 2022[J]. J Inflamm Res, 2023, 16: 2763-2771. DOI: 10.2147/JIR.S413050.
|
12. |
Dutta Majumder P, Agarwal A. Acute macular neuroretinopathy and paracentral acute middle maculopathy during SARS-CoV-2 infection and vaccination[J]. Vaccines (Basel), 2023, 11(2): 474. DOI: 10.3390/vaccines11020474.
|
13. |
Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients[J]. Ocul Immunol Inflamm, 2020, 28: 721-725. DOI: 10.1080/09273948.2020.1770301.
|
14. |
Ahmed W, Suri A, Ahmed A. COVID-19 and acute macular neuroretinopathy - an underlying association?[J/OL]. Ann Med Surg (Lond), 2022, 78: 103847[2022-05-26]. https://pubmed.ncbi.nlm.nih.gov/35734676/. DOI: 10.1016/j.amsu.2022.103847.
|
15. |
Hansen SO, Cooper RF, Dubra A, et al. Selective cone photoreceptor injury in acute macular neuroretinopathy[J]. Retina, 2013, 33(8): 1650-1658. DOI: 10.1097/IAE.0b013e31828cd03a.
|
16. |
Iovino C, Au A, Ramtohul P, et al. Coincident PAMM and AMN and insights into a common pathophysiology[J]. Am J Ophthalmol, 2022, 236: 136-146. DOI: 10.1016/j.ajo.2021.07.004.
|
17. |
Chan WM, Liu DT, Tong JP, et al. Longitudinal findings of acute macular neuroretinopathy with multifocal electroretinogram and optical coherence tomography[J]. Clin Exp Ophthalmol, 2005, 33(4): 439-442. DOI: 10.1111/j.1442-9071.2005.01006.x.
|
18. |
Luhtala S, Vaajanen A, Oksala O, et al. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues[J]. J Ocul Pharmacol Ther, 2009, 25(1): 23-28. DOI: 10.1089/jop.2008.0081.
|
19. |
Menuchin-Lasowski Y, Schreiber A, Lecanda A, et al. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids[J]. Stem Cell Reports, 2022, 17(4): 789-803. DOI: 10.1016/j.stemcr.2022.02.015.
|
20. |
Albertos-Arranz H, Martínez-Gil N, Sánchez-Sáez X, et al. Microglia activation and neuronal alterations in retinas from COVID-19 patients: correlation with clinical parameters[J]. Eye Vis (Lond), 2023, 10(1): 12. DOI: 10.1186/s40662-023-00329-2.
|
21. |
Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival[J]. Nat Med, 2020, 26(10): 1636-1643. DOI: 10.1038/s41591-020-1051-9.
|
22. |
Monu M, Ahmad F, Olson RM, et al. SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure[J/OL]. PLoS Pathog, 2024, 20(4): e1012156[2024-04-10]. https://pubmed.ncbi.nlm.nih.gov/38598560/. DOI: 10.1371/journal.ppat.1012156.
|
23. |
Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF‐kappaB[J]. Cell Death Differ, 2006, 13: 759-772. DOI: 10.1038/sj.cdd.4401838.
|
24. |
Nguyen LN, Kanneganti TD. PANoptosis in viral infection: the missing puzzle piece in the cell death field[J/OL]. J Mol Biol, 2022, 434(4): 167249[2022-02-28]. https://pubmed.ncbi.nlm.nih.gov/34537233/. DOI: 10.1016/j.jmb.2021.167249.
|
25. |
Neufeldt CJ, Cerikan B, Cortese M, et al. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB[J]. Commun Biol, 2022, 5(1): 45. DOI: 10.1038/s42003-021-02983-5.
|
26. |
Li MY, Li L, Zhang Y, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues[J]. Infect Dis Poverty, 2020, 9(1): 5. DOI: 10.1186/s40249-020-00662-x.
|
27. |
Lukiw WJ, Pogue AI, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain[J]. Cell Mol Neurobiol, 2022, 42(1): 217-224. DOI: 10.1007/s10571-020-00947-7.
|
28. |
Edo A, Sugita S, Futatsugi Y, et al. Capacity of retinal ganglion cells derived from human induced pluripotent stem cells to suppress T-cells[J]. Int J Mol Sci, 2020, 21(1): 7831. DOI: 10.3390/ijms21217831.
|
29. |
Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye[J/OL]. J Ophthalmol, 2020, 2020: 4827304[2020-08-27]. https://pubmed.ncbi.nlm.nih.gov/32963819/. DOI: 10.1155/2020/4827304.
|